Intranasal Vaccine Administration

Intranasal administration of vaccines has recently proven to be one of the most efficient ways for inducing both mucosal and systemic antibody responses in experimental animals. The needle-free nature of nasal delivery also offers hopes of improved patient compliance. In recent testing at the Center for Disease Control and Prevention, three different ViaNase device configurations aerosolized live attenuated measles virus without loss of potency.

  Home | Nasal Drug Delivery | Technology | Clinical Studies | Devices | Investors | News & Events | About Kurve | Contact

Copyright 2020, Kurve Technology, Inc. All Rights Reserved | Site Map
Technology Marketing